• Antifibrotic Medication Monographs

    Detailed product monograph for OFEV (updated 2021) Detailed product monograph for Esbriet (updated 2021)

  • Patient Information Leaflets (PILs)

    Nintedanib (OFEV) Pirfenidone (Esbriet)

  • Drug Coverage by Province

    Explore drug coverage for each province and territory in Canada

  • 2025

    Harmonizing domiciliary oxygen therapy in Canada

  • 2024

    Reliability of crackles in fibrotic interstitial lung disease: a prospective, longitudinal study Integration and Application of Radiologic Patterns From Clinical Practice Guidelines on Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis

  • 2023

    Dec 2023Integration and Application of Radiologic Patterns From Clinical Practice Guidelines on Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis Early versus late onset interstitial lung disease in rheumatoid arthritis: An observational study of risk factors and mortality in Ontario, Canada July 2023The interplay of physical and cognitive function in rehabilitation of interstitial lung disease patients:…

  • 2022

    November 2022Pregnancy Considerations for Patients With Interstitial Lung Disease August 2022Perceptions of Genetic Testing: A Mixed-Methods Study of Patients with Pulmonary Fibrosis and Their First-Degree Relatives Interstitial Lung Disease in ANCA‑Associated Vasculitis: Pathogenic Considerations and Impact for Patients’ Outcomes Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosis February…

  • 2021

    December 2021Malignancy Risk Associated with the use of Mycophenolate Mofetil in Interstitial Lung Disease September 2021Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases August 2021Feasibility and Outcomes of a Standardized Management Protocol for Acute Exacerbation of Interstitial Lung Disease Cell-specific drug targeting in the lung

  • 2020

    September 2020Frailty in patients with interstitial lung disease Long-term monitoring of patients with fibrotic interstitial lung disease: A Canadian Thoracic Society position statement August 2020Sputum quantitative cytometry in patients with interstitial lung disease and chronic cough Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters? May…

  • 2019

    November 2019Baseline characteristics and comorbidities in the Canadian Registry for Pulmonary Fibrosis Management of idiopathic pulmonary fibrosis: A survey of Canadian respirologists March 2019Screening for Myositis Antibodies in Idiopathic Interstitial Lung Disease Feb 2019Oxygen in patients with fibrotic interstitial lung disease: an international Delphi survey January 2019Procedure volume and mortality after surgical lung biopsy in…